Steen LISBY

Person

Frederiksberg, DK

People

Patents Grantslast 30 patents

Information Patent Grant
Human antibodies and antibody-drug conjugates against CD74
- Patent number 9,540,433
- Issue date Jan 10, 2017
- Genmab A/S
- Sandra Verploegen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating rash in patients undergoing anti-EGFR therapy
- Patent number 9,428,582
- Issue date Aug 30, 2016
- Genmab A/S
- Klaus Edvardsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibody drug conjugates against tissue factor
- Patent number 9,168,314
- Issue date Oct 27, 2015
- Genmab A/S
- David Satijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination treatment of CD38-expressing tumors
- Patent number 9,040,050
- Issue date May 26, 2015
- Genmab A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20240294661
- Publication date Sep 5, 2024
- GENMAB A/S
- David SATIJN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TR...
- Publication number 20240252673
- Publication date Aug 1, 2024
- GENMAB A/S
- Reshma A. RANGWALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20240165226
- Publication date May 23, 2024
- GENMAB A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74
- Publication number 20220323582
- Publication date Oct 13, 2022
- GENMAB A/S
- Sandra VERPLOEGEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
- Publication number 20220265844
- Publication date Aug 25, 2022
- GENMAB A/S
- Steen LISBY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20210395384
- Publication date Dec 23, 2021
- GENMAB A/S
- David SATJIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TR...
- Publication number 20210177987
- Publication date Jun 17, 2021
- GENMAB A/S
- Reshma Abdulla RANGWALA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20200114000
- Publication date Apr 16, 2020
- GENMAB A/S
- Jan Van De Winkel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20190315880
- Publication date Oct 17, 2019
- GENMAB A/S
- David SATIJN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEW DOSAGE REGIMENS FOR ANTIBODY DRUG CONJUGATES BASED ON ANTI-AXL...
- Publication number 20190233522
- Publication date Aug 1, 2019
- GENMAB A/S
- Ulf FORSSMANN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
- Publication number 20190030178
- Publication date Jan 31, 2019
- GENMAB A/S
- Steen LISBY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74
- Publication number 20170173151
- Publication date Jun 22, 2017
- GENMAB A/S
- Sandra VERPLOEGEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20170136130
- Publication date May 18, 2017
- GENMAB A/S
- David SATIJN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20160067349
- Publication date Mar 10, 2016
- GENMAB A/S
- David Satijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20150231235
- Publication date Aug 20, 2015
- GENMAB A/S
- Jan VAN DE WINKEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74
- Publication number 20140030273
- Publication date Jan 30, 2014
- GENMAB A/S
- Sandra Verploegen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20130101608
- Publication date Apr 25, 2013
- GENMAB A/S
- David Satijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD20 Binding Molecules for the Treatment of Copd
- Publication number 20130004480
- Publication date Jan 3, 2013
- Paul Parren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OF RASH IN PATIENTS UNDERGOING ANTI-EGFR THERAPY
- Publication number 20100150936
- Publication date Jun 17, 2010
- GENMAB A/S
- Klaus Edvardsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS
- Publication number 20100092489
- Publication date Apr 15, 2010
- GENMAB A/S
- Jan Van De Winkel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Steen LISBY

Person

Patents Grantslast 30 patents

Human antibodies and antibody-drug conjugates against CD74

Method of treating rash in patients undergoing anti-EGFR therapy

Human antibody drug conjugates against tissue factor

Combination treatment of CD38-expressing tumors

Patents Applicationslast 30 patents

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TR...

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TR...

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

NEW DOSAGE REGIMENS FOR ANTIBODY DRUG CONJUGATES BASED ON ANTI-AXL...

DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

CD20 Binding Molecules for the Treatment of Copd

PREVENTION OF RASH IN PATIENTS UNDERGOING ANTI-EGFR THERAPY

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS